Investor.bridgebio.com

  1. Home
  2. Investor.bridgebio.com

BridgeBio BridgeBio Pharma, Inc. Appoints Pioneering National …

WEBPALO ALTO, Calif., Oct. 25, 2021 /PRNewswire/ -- BridgeBio Pharma, Inc. (Nasdaq: BBIO), a commercial-stage biopharmaceutical company focused on genetic diseases and …

Actived: 2 days ago

URL: https://investor.bridgebio.com/news-releases/news-release-details/bridgebio-pharma-inc-appoints-pioneering-national-leader

BridgeBio BridgeBio Pharma, Inc. and Oregon Health & Science

WEBPALO ALTO, Calif., April 13, 2021 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (NASDAQ: BBIO) today announced a collaboration with Oregon Health & Science …

Category:  Health Go Health

BridgeBio BridgeBio announces consistently positive results from

WEB- Highly statistically significant result observed on primary endpoint with a Win Ratio of 1.8 (p<0.0001)- 58% of ties in Finkelstein-Schoenfeld (F-S) primary analysis …

Category:  Health Go Health

BridgeBio BridgeBio Pharma Announces First Lung Cancer Patient …

WEB- BBP-398, an investigational SHP2 inhibitor, is a potentially optimal agent for use in combination therapies given its continuous, once-daily dosing in addition to …

Category:  Health Go Health

BridgeBio BridgeBio Pharma Presents Updated Results from …

WEB- NT-proBNP, a biomarker of cardiac failure and independent predictor of mortality in ATTR-CM patients, was stable or improving throughout the study. At Month …

Category:  Health Go Health

BridgeBio BridgeBio Announces First Child Dosed in PROPEL 3, its

WEB- BridgeBio has dosed the first child in PROPEL 3, a one-year, 2:1 randomized, placebo-controlled Phase 3 pivotal trial evaluating the efficacy and safety of …

Category:  Health Go Health

BridgeBio BridgeBio Pharma Shares Positive Results of Single …

WEB- Phase 3 open-label, single-arm study conducted in Japan by BridgeBio licensing partner Alexion, AstraZeneca Rare Disease showed consistency with global …

Category:  Health Go Health

BridgeBio BridgeBio Pharma’s Affiliate QED Therapeutics and …

WEBPivotal study demonstrated a clinically meaningful rate of tumor shrinkage (overall response rate) and duration of response in patients with previously-treated …

Category:  Health Go Health

BridgeBio BridgeBio Pharma Announces Submission of New Drug

WEB- NDA submission is based on positive results from ATTRibute-CM Phase 3 study, including a highly statistically significant result, demonstrated by a Win Ratio of …

Category:  Health Go Health

BridgeBio Pharma to Participate in November Investor Events

WEBBridgeBio Pharma to Participate in November Investor Events. 11.09.2022 at 7:30 AM EST. PALO ALTO, Calif., Nov. 09, 2022 (GLOBE NEWSWIRE) -- BridgeBio …

Category:  Health Go Health

BridgeBio BridgeBio Pharma Announces New England Journal of …

WEB- In our study, encaleret restored physiologic mineral homeostasis in 13 participants with ADH1, specifically correcting hypocalcemia and reducing hypercalciuria …

Category:  Health Go Health

BridgeBio BridgeBio Pharma Initiates CALIBRATE, A Pivotal Phase …

WEB- The CALIBRATE Phase 3 study design incorporates feedback from global regulatory agencies and will compare the effects of encaleret to standard of care on …

Category:  Health Go Health

BridgeBio BridgeBio Pharma and Kyowa Kirin Announce …

WEB- BridgeBio grants Kyowa Kirin exclusive license to develop and commercialize infigratinib for skeletal dysplasias in Japan - BridgeBio to receive upfront …

Category:  Health Go Health

BridgeBio Burjeel Holdings to Launch Rare Disease Research

WEB– Project ‘NADER’ is intended to span multiple phases, starting from mapping rare diseases in the UAE and wider region through innovative risk assessment …

Category:  Health Go Health

BridgeBio BridgeBio Pharma and Bayer Announce European …

WEB- BridgeBio grants Bayer exclusive license to commercialize acoramidis as a treatment for patients with transthyretin amyloid cardiomyopathy (ATTR-CM) in Europe - …

Category:  Health Go Health

Adora Ndu, Pharm.D., J.D. Management BridgeBio Pharma

WEBAdora Ndu has served as our Chief Regulatory Affairs Officer since January 2022. Prior to joining BridgeBio, she held various leadership positions at BioMarin Pharmaceutical …

Category:  Health Go Health

j.p. morgan healthcare conference BridgeBio Pharma

WEBThe Investor Relations website contains information about BridgeBio Pharma's business for stockholders, potential investors, and financial analysts.

Category:  Health Go Health

Top Categories

 › Appendicitis

 › Headaches

 › Gout

 › Women's Health

 › Thyroid

 › Sleep

 › Skin

 › Sexual Health

 › Senior Health

 › Pregnancy

 › Oral Health

 › Neurology

 › Migraine

 › Mental Health

 › Men's Health

 › Menopause

 › Medications

 › Lung Conditions

 › Infectious Disease

 › HIV/AIDS

Popular Searched

 › Healthy hound dunnellon fl

 › Sheffield health and wellbeing

 › Csumb student health rates

 › Provider definition health care

 › Health benefits of yellow melon

 › United health care group number

 › Healthcare climate action report

 › Csumb campus health center patient portal

 › Law school mental health statistics

 › Healthcare without harm road map

Recently Searched

 › Amerihealth caritas florida member services

 › Health edge health care

 › Lifeline of jackson buy home health

 › Nsw mental health director

 › Indiana university health inc

 › Honor health family doctors

 › New york harbor health care va

 › Health insurance in romania for expats

 › Global health scholars yale

 › Yeshasvini card health insurance